PDK1 Attenuation Fails to Prevent Tumor Formation in PTEN-Deficient Transgenic Mouse Models

This study employed a novel RNAi approach useful for context-dependent target validation in vivo, applying it to demonstrate that the protein kinase PDK1 is not a rate limiting factor for PI3K-pathway activation or tumor formation in PTEN-deficient mouse models.